NATIXIS - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
NATIXIS ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$166,458
-86.3%
4,104
-78.9%
0.00%
-75.0%
Q3 2021$1,217,000
-72.7%
19,486
-66.4%
0.00%
-75.0%
Q4 2020$4,450,000
+419.9%
58,000
+191.9%
0.02%
+166.7%
Q3 2020$856,000
-65.8%
19,870
-65.7%
0.01%
-68.4%
Q2 2020$2,505,000
+966.0%
58,000
+610.8%
0.02%
+850.0%
Q1 2020$235,000
-93.6%
8,160
-85.8%
0.00%
-91.3%
Q4 2019$3,680,00057,3270.02%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders